2025-05-14T13:24:43-05:00 2024-06-30 450250958 EIDE BAILLY LLP 2355 E CAMELBACK RD STE 900 PHOENIX AZ 850169065 990 2023-07-01 860174371 BARROW NEUROLOGICAL FOUNDATION BARR 6024063041 2910 N 3RD AVE STE 450 PHOENIX AZ 85013 STACY TUCKER TREASURER 6024063041 2025-05-14 1 1 BRENDA ANN BLUNT CPA P00075126 4803151040 2025-05-14 2023 2025-03-06 01:10:19Z DR MITCHEL SAYARE 2910 N 3RD AVE STE 450 PHOENIX AZ 85013 156876469 0 X WWW.SUPPORTBARROW.ORG X 1961 AZ TO SUPPORT BARROW NEUROLOGICAL INSTITUTE, A DIVISION OF DIGNITY HEALTH. 39 38 0 38 0 0 30874199 52977678 0 6865559 3679337 24152251 -293811 -423036 34259725 83572452 47257411 20770004 0 0 0 0 0 0 1321274 8894080 17098977 56151491 37868981 -21891766 45703471 226235827 264153308 11956006 9984000 214279821 254169308 X TO SUPPORT BARROW NEUROLOGICAL INSTITUTE, A DEPARTMENT OF ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER, WHICH IS IN TURN A DIVISION OF DIGNITY HEALTH. 0 1 20770004 20770004 THE FOUNDATION RAISES FUNDS TO SUPPORT BARROW NEUROLOGICAL INSTITUTE, A DEPARTMENT OF ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER IN PHOENIX, ARIZONA, WHICH IS A DIVISION OF DIGNITY HEALTH, A CALIFORNIA NONPROFIT BENEFIT CORPORATION. 12530670 6865559 NEUROTRIALS CONDUCTS RESEARCH WHICH IS SINGULARLY FOCUSED ON DISCOVERING NEW THERAPIES FOR BRAIN TUMOR PATIENTS THROUGH A BROAD PORTFOLIO OF PHARMACODYNAMIC- AND PHARMACOKINETIC-DRIVEN CLINICAL TRIALS, COMBINING INDUSTRY-PARTNERED DRUG DEVELOPMENT WITH THE NATION'S LARGEST OPERATIVE BRAIN TUMOR VOLUME. 33300674 1 1 0 0 0 0 0 0 0 1 0 1 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 1 10 0 1 0 0 0 0 0 0 1 1 0 0 0 0 0 0 X 39 38 0 0 0 0 0 1 1 1 1 0 0 0 1 1 1 1 1 0 0 0 X JACKIE ASSINK 6024063041 2910 N 3RD AVENUE SUITE 450 PHOENIX AZ 85013 MITCHEL SAYARE BOARD CHAIR 1.00 X X 0 0 0 DONNA JOHNSON VICE CHAIR 1.00 X X 0 0 0 ELLEN KATZ BOARD SECRETARY/ DIRECTOR 1.00 X X 0 0 0 JAMES SWANSON TREASURER 1.00 X X 0 0 0 IRA FULTON DIRECTOR 1.00 X 0 0 0 ROBERT LAVINIA DIRECTOR 1.00 X 0 0 0 MICHAEL LAWTON DIRECTOR 1.00 X 0 0 0 W KENT MCCLELLAND DIRECTOR 1.00 X 0 0 0 DAN BURNS DIRECTOR 1.00 X 0 0 0 MITCHELL PIERCE DIRECTOR 1.00 X 0 0 0 CHRIS HOWARD DIRECTOR 1.00 X 0 0 0 JANET MARTIN DIRECTOR 1.00 X 0 0 0 EARL PETZNICK JR DIRECTOR 1.00 X 0 0 0 LAURIE TERMANSEN DIRECTOR 1.00 X 0 0 0 MAL JOZOFF DIRECTOR 1.00 X 0 0 0 MIKE LOVELL DIRECTOR 1.00 X 0 0 0 SHANNON MISHKIN DIRECTOR 1.00 X 0 0 0 ROBERT UHL DIRECTOR 1.00 X 0 0 0 LISA HANDLEY DIRECTOR 1.00 X 0 0 0 DAVID RAUCH DIRECTOR 1.00 X 0 0 0 RICHARD DAVIS DIRECTOR 1.00 X 0 0 0 DIONNE NAJAFI DIRECTOR 1.00 X 0 0 0 JORDAN ROSE DIRECTOR 1.00 X 0 0 0 STACY TUCKER DIRECTOR 1.00 X 0 0 0 DAVID VAN DENBURGH DIRECTOR 1.00 X 0 0 0 JEAN FEUER DIRECTOR 1.00 X 0 0 0 AMANDA GARMANY DIRECTOR 1.00 X 0 0 0 BRADLEY GROSSMAN DIRECTOR 1.00 X 0 0 0 MARGOT KNIGHT DIRECTOR 1.00 X 0 0 0 LAURIE CARSON DIRECTOR 1.00 X 0 0 0 ADAM LEVIN DIRECTOR 1.00 X 0 0 0 JONATHAN LEVINE DIRECTOR 1.00 X 0 0 0 MARKOS TAMBAKERAS DIRECTOR 1.00 X 0 0 0 HEIDI J TEETS DIRECTOR 1.00 X 0 0 0 ROBERT SPETZLER DIRECTOR 1.00 X 0 0 0 SHARON STONE DIRECTOR 1.00 X 0 0 0 ANDY MCCAIN DIRECTOR 1.00 X 0 0 0 MARNE OBERNAUER JR DIRECTOR 1.00 X 0 0 0 KATHERINE COBB PRESIDENT 1.00 X X 402717 0 32876 402717 0 32876 1 0 1 1 MERCER INVESTMENTS LLC 21875 NETWORK PLACE CHICAGO IL 60673 CONSULTING 215750 MILLIGAN LAWLESS PC 5050 N 40TH ST SUITE 200 PHOENIX AZ 85018 LEGAL SERVICES 151523 COMMUNITY COUNSELING SERVICE CO LLC 527 MADISON AVENUE 5TH FLOOR NEW YORK NY 10022 CONSULTING 137500 3 7164823 45812855 2595414 52977678 CLINICAL TRIALS 541700 6853999 6853999 OTHER INCOME 541700 11560 11560 6865559 3448805 3448805 93206904 72503458 20703446 20703446 20703446 377523 7164823 800559 -423036 -423036 83572452 6865559 0 23729215 X 20770004 20770004 530404 175341 355063 64560 64560 376538 376538 11969428 11392860 569861 6707 794302 23559 770571 172 360582 85487 75047 200048 127093 63707 63386 215328 192868 17627 4833 39886 35030 4856 MISC EXPENSES 1656508 6801 827428 822279 LAB SUPPLIES 343607 343607 EQUIPMENT 148268 148253 15 PURCHASED SERVICES 141172 141172 331301 63157 122081 146063 37868981 33300674 3247033 1321274 11484931 12232354 2337953 1350099 54992079 45440694 101728 3368212 804035 0 126337778 151894671 30149912 49839867 27411 27411 226235827 264153308 8215576 3831216 3523566 4020139 31370 0 185494 2132645 11956006 9984000 X 37887003 44620951 176392818 209548357 214279821 254169308 226235827 264153308 X 45703471 -4624251 -1189733 X 0 0 0 X 23698092 50826228 44857602 29074199 52977678 201433799 23698092 50826228 44857602 29074199 52977678 201433799 79159100 122274699 2018326 1484139 2056820 3205102 3448805 12213192 254175 254175 501 4833 838 6172 213907338 6865559 0.57160 0.56680 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS REVENUE - 2020 AMOUNT: $ 501. 2021 AMOUNT: $ 4,833. 2022 AMOUNT: $ 838. 2023 AMOUNT: $ 0. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 91863973 4279486 8758994 2313527 102588926 79581148 7994116 5672803 1384094 91863973 67729545 23470001 -10027792 1590606 79581148 59820070 303795 9458184 1852504 67729545 57635268 2303686 1645714 1764598 59820070 0.07000 0.73000 0.20000 0 0 0 PARTNERSHIPS 24852527 F PASSIVE FOREIGN INVESTMENT COMPANIES 24987340 F 49839867 SPLIT INTEREST AGREEMENTS 176149 CONTRACT LIABILITY 1956496 2132645 PART V, LINE 4: ENDOWMENT FUNDS ARE USED TO SUPPORT THE BARROW NEUROLOGICAL INSTITUTE'S RESEARCH AND MEDICAL EDUCATION PROGRAMS CENTRAL AMERICA/CARIBBEAN 0 0 INVESTMENTS N/A 19794323 EUROPE 0 0 INVESTMENTS N/A 10145666 0 0 0 0 0 0 29939989 0 29939989 1 0 1 1 1 0 PART I, LINE 3: NO EXPENDITURES ARE REPORTED ON SCHEDULE F, PART I. ALL AMOUNTS REFLECT INVESTMENTS PER REGION. BARROW BALL 5163189 5096969 66220 182008 13500 20181 NEURO NIGHT 2379157 2067854 311303 250438 167697 25000 141735 7542346 7164823 377523 250438 349705 38500 161916 800559 -423036 1 DIGNITY HEALTH DBA ST JOSEPHS HOSPITAL & MEDICAL CENTER 350 W THOMAS ROAD PHOENIX AZ 85013 941196203 501(C)(3) 20770004 0 SUPPORT HOSPITAL 1 0 PART I, LINE 2: THE FOUNDATION OPERATES EXCLUSIVELY FOR THE BENEFIT OF, TO PERFORM THE FUNCTIONS OF, OR TO CARRY OUT THE PURPOSES OF THE GRANTEE LISTED IN PART II, ITEM 1 (DIGNITY HEALTH, DBA ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER), WHICH INCLUDES MAKING DISTRIBUTIONS DIRECTLY TO THE BENEFICIARY ORGANIZATION, TRANSFERRING AND MONITORING THAT RESTRICTIONS ARE MET BEFORE RELEASE OF FUNDS, AND EXPENDITURE OF SUCH FUNDS. 0 0 0 0 0 0 0 0 0 KATHERINE COBB PRESIDENT 304243 0 94799 0 3675 0 30352 0 2524 0 435593 0 0 0 PART I, LINE 3 THE FOUNDATION RELIED ON AN UNRELATED ORGANIZATION, DIGNITY HEALTH, THAT USED ONE OR MORE OF THE METHODS DESCRIBED IN SCHEDULE J, PART I, LINE 3 TO ESTABLISH THE COMPENSATION OF THE PERSON WHO IS THE TOP MANAGEMENT OFFICIAL FOR THIS ORGANIZATION. SEE FORM 990, PART VI, SECTION B, LINE 15 SCHEDULE O DISCLOSURE FOR ADDITIONAL INFORMATION. SCHEDULE J, PART II: COMPENSATION FROM AN UNRELATED ORGANIZATION THE ORGANIZATION'S CEO, KATHERINE COBB, IS COMPENSATED BY DIGNITY HEALTH, AN UNRELATED ORGANIZATION. 2023 CALENDAR YEAR COMPENSATION AND EMPLOYER PROVIDED BENEFITS FOR KATHERINE ARE REPORTED ON SCHEDULE J, PART II AND FORM 990, PART VII, SECTION A, AS COMPENSATION FROM THE ORGANIZATION. COMPENSATION: $402,718 PENSION: $30,352 NONTAXABLE BENEFITS: $2,524 SCHEDULE J, PART II, SUPPLEMENTAL DISCLOSURES ALL EMPLOYEES ARE LEASED FROM DIGNITY HEALTH ("HOSPITAL") AND THEIR COMPENSATION AND BENEFITS ARE SET BY THE HOSPITAL. THE HOSPITAL'S EXECUTIVE COMPENSATION PHILOSOPHY IS DESIGNED TO ASSIST IN ATTRACTING AND RETAINING THE CALIBER OF EXECUTIVES REQUIRED TO FULFILL ITS MISSION OF PROVIDING HIGH QUALITY HEALTHCARE FOR ALL PERSONS REGARDLESS OF THEIR ABILITY TO PAY FOR SERVICES, IMPROVING THE QUALITY OF LIFE IN THE COMMUNITIES THE ORGANIZATION SERVES, PROMOTING EMPLOYEE SATISFACTION, AND ENSURING FINANCIAL STABILITY. A SUBSTANTIAL PORTION OF EXECUTIVE COMPENSATION IS PERFORMANCE BASED AND IS LINKED TO ORGANIZATIONAL GOALS APPROVED IN ADVANCE BY THE HOSPITAL'S HUMAN RESOURCES AND COMPENSATION COMMITTEE. THESE GOALS INCLUDE ATTAINMENT OF ANNUAL AND LONG-TERM FINANCIAL PERFORMANCE, CERTAIN HEALTHCARE QUALITY STANDARDS AND THE HOSPITAL'S COMMITMENT TO SERVING THE POOR AND DISENFRANCHISED IN THE COMMUNITIES IT SERVES. TOTAL COMPENSATION, WHICH INCLUDES BASE SALARY, ANNUAL AND LONG-TERM INCENTIVE COMPENSATION, TARGETS THE 25TH PERCENTILE OF THE MARKET IN WHICH THE HOSPITAL COMPETES FOR EXECUTIVES, COMMENSURATE WITH THE SIZE AND COMPLEXITY OF THE ORGANIZATION. X 66 2225696 FAIR MARKET VALUE X LIVE AUCTION PRIZES 20 208624 COMPARABLE SALES X AIRLINE FLIGHT TICKETS 1 63250 COMPARABLE SALES X EQUIPMENT 3 61966 COMPARABLE SALES X MISCELLANEOUS ITEMS 6 23175 COMPARABLE SALES X HOTEL ACCOMODATIONS 1 9500 COMPARABLE SALES X OTHER FOOD & BEVERAGES 2 3203 COMPARABLE SALES 0 0 1 0 PART I, COLUMN (B): THE AMOUNT IN COLUMN (B) IS THE NUMBER OF CONTRIBUTIONS CONTRIBUTED. FORM 990, PART I, LINE 5 AND PART V, LINE 2A THE ORGANIZATION DOES NOT HAVE EMPLOYEES. THE FOUNDATION OPERATES FOR THE BENEFIT OF THE HOSPITAL AND UTILIZES THE EMPLOYEES OF THAT HOSPITAL. THE PROPORTIONATE SALARIES AND BENEFITS FOR THESE INDIVIDUALS ARE ALLOCATED TO THE FOUNDATION. THE SALARIES OF THESE EMPLOYEES ARE INCLUDED IN THE HOSPITAL ENTITY'S FORM W-3 AND FEDERAL EMPLOYMENT TAX RETURNS. FORM 990, PART III, LINE 3 NEUROTRIALS, IS A WHOLLY-OWNED SUBSIDIARY OF THE ORGANIZATION AND IS AN ENTITY THAT IS DISREGARDED AS SEPARATE FROM THE ORGANIZATION FOR TAX PURPOSES. NEUROTRIALS HAS LONG CONDUCTED RESEARCH, INCLUDING CLINICAL TRIALS, WITH THE SINGULAR FOCUS OF DISCOVERING NEW THERAPIES FOR BRAIN TUMOR PATIENTS. BECAUSE THE ORGANIZATION'S EXEMPT PURPOSE IS TO SUPPORT BARROW NEUROLOGICAL INSTITUTE, THIS RESEARCH FALLS WITHIN THE ORGANIZATION'S EXEMPT PURPOSE AS THE PRIMARY PURPOSE OF THE RESEARCH IS TO BENEFIT THE PATIENTS OF BARROW NEUROLOGICAL INSTITUTE. OVER THE LONG-TERM, THE ORGANIZATAION IS ALSO HOPING TO HAVE A WORLD-WIDE IMPACT BY IDENTIFYING NEW TREATMENTS AND CURES FOR BRAIN TUMORS. THIS YEAR THE ORGANIZATION CHANGED HOW IT CONDUCTS THIS WORK BY ADDING A SPONSORED TRIAL TO ITS PORTFOLIO OF RESEARCH PROJECTS. THE ORGANIZATION ENTERED INTO A CONTRACT WITH A PHARMACEUTICAL COMPANY TO CONDUCT A PHASE III CLINICAL TRIAL ON A DRUG WHICH IS PATENTED BY THE SPONSORING PHARMACEUTICAL COMPANY AND SHOWS SOME PROMISE AS A POTENTIAL TREATMENT FOR A PARTICULAR TYPE OF BRAIN TUMOR. THE DRUG IS ALREADY APPROVED BY THE FDA FOR A LIMITED RANGE OF RARE CANCERS, BUT NONE IN THE BRAIN. THE PRIMARY BENEFIT OF THIS PARTICULAR STUDY THE POTENTIAL THERAPEUTIC BENEFITS TO PATIENTS OF BARROW NEUROLOGICAL INSTITUTE, WITH A SECONDARY EMPHASIS ON THE POTENTIAL BENEFIT TO BRAIN TUMOR PATIENTS WORLDWIDE. THE SIGNIFICANT BENEFIT TO CURRENT BARROW NEUROLOGICAL INSTITUTE PATIENTS WITH THIS LIFE-THREATENING CANCER OUTWEIGHS ANY BENEFIT TO THE PHARMACEUTICAL COMPANY. FORM 990, PART VI, SECTION A, LINE 1A THE FOUNDATION HAS AN EXECUTIVE COMMITTEE, WHICH CONSISTS OF THE CHAIR, VICE CHAIR, SECRETARY AND TREASURER OF THE BOARD OF TRUSTEES AND THE PRESIDENT OF THE ORGANIZATION. THE CHAIR OF THE BOARD SERVES AS THE CHAIR OF THE EXECUTIVE COMMITTEE AS WELL. THE EXECUTIVE COMMITTEE IS NOT AUTHORIZED, WITHOUT THE APPROVAL OF A MAJORITY OF THE TRUSTEES PRESENT, IN PERSON AT A DULY CONVENED MEETING AT WHICH A QUORUM IS PRESENT, TO TAKE ANY ACTIONS THAT REQUIRE THE APPROVAL OF THE BOARD OF TRUSTEES. FORM 990, PART VI, SECTION A, LINE 7A THE PRESIDENT OF ST. JOSEPH'S HOSPITAL AND MEDICAL CENTER, A DIVISION OF DIGNITY HEALTH; THE PRESIDENT AND CEO OF BARROW NEUROLOGICAL INSTITUTE, A DIVISION OF DIGNITY HEALTH; THE CHAIR OF THE WOMEN'S BOARD, AN INTERNAL AUXILLARY OF THE FOUNDATION; AND THE FOUNDATION'S PRESIDENT ARE EACH EX OFFICIO MEMBERS OF THE BOARD. THE FOUNDATION'S PRESIDENT IS APPOINTED BY, AND SERVES AT THE PLEASURE OF, THE PRESIDENT AND CEO OF BARROW NEUROLOGICAL INSTITUTE. FORM 990, PART VI, SECTION A, LINE 7B DIGNITY HEALTH, A 501(C)(3) ORGANIZATION, MUST APPROVE ANY CHANGES TO THE ARITICLES OF INCORPORATION OR THE BYLAWS OF THE FOUNDATION THAT WOULD HAVE THE EFFECT OF CHANGING THE FOUNDATION'S NAME OR PURPOSE. IN THE EVENT THE BOARD VOTES ARE DEADLOCKED ON ANY ISSUE, THE PRESIDENT AND CEO OF BARROW NEUROLOGICAL INSTITUTE HAS THE AUTHORITY TO DECIDE THE ISSUE. BARROW NEUROLOGICAL INSTITUTE IS A DIVISION OF DIGNITY HEALTH. FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION'S VICE PRESIDENT OF OPERATIONS AND FINANCE, FINANCE AND INVESTMENT COMMITTEE, AND CHAIR OF THE AUDIT COMMITTEE HAVE REVIEWED THE ANNUAL FORM 990 PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C THE FOUNDATION HAS ADOPTED DIGNITY HEALTH'S CONFLICT OF INTEREST POLICY. THE FOUNDATION'S BOARD IS CHARGED WITH MONITORING PROPOSED OR ONGOING TRANSACTIONS FOR CONFLICTS OF INTEREST AND ADDRESSING ANY POTENTIAL OR ACTUAL CONFLICTS. PURSUANT TO THE CONFLICT OF INTEREST POLICY, AN ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE, AIMED AT DETERMINING ANY FAMILY AND BUSINESS RELATIONSHIPS AND TRANSACTIONS OR OTHER TRANSACTIONS THAT MAY POSE A POTENTIAL CONFLICT, IS DISTRIBUTED TO ALL COVERED PERSONS (E.G., BOARD MEMBERS, OFFICERS AND EXECUTIVE LEADERSHIP, KEY EMPLOYEES). COVERED PERSONS ARE REQUIRED TO DISCLOSE REAL OR POTENTIAL CONFLICTS AT THE TIME SUCH CONFLICTS ARISE. WHEN AN INDIVIDUAL BECOMES A COVERED PERSON AND ANNUALLY THEREAFTER, EACH COVERED PERSON IS REQUIRED TO SUBMIT AN UPDATED DISCLOSURE STATEMENT AND TO SIGN A STATEMENT AFFIRMING THAT HE/SHE: (1) HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY; (2) HAS READ THE POLICY AND UNDERSTANDS SAID POLICY; AND (3) AGREES TO COMPLY WITH ALL REQUIREMENTS OF THE POLICY, INCLUDING COMPLETING THE CONFLICT OF INTEREST DISCLOSURE STATEMENT. THE COMPLETED QUESTIONNAIRES ARE REVIEWED BY DIGNITY HEALTH'S LEGAL DEPARTMENT AND ANY PERSONS WITH ACTUAL OR POTENTIAL CONFLICTS ARE INFORMED VIA WRITTEN COMMUNICATION. THE PROCEDURES FOR ADDRESSING ANY CONFLICT OF INTEREST INCLUDE, BUT ARE NOT LIMITED TO, THE FOLLOWING: (1) THE CONFLICTING INTEREST IS FULLY DISCLOSED TO THE BOARD; (2) THE INTERESTED PERSON RESPONDS TO FACTUAL QUESTIONS RELATED TO THE SUBSTANCE OF THE TRANSACTION OR ARRANGEMENT BEING CONSIDERED, AFTER WHICH HE/SHE SHALL LEAVE THE MEETING; (3) THE PERSON WITH THE CONFLICT OF INTEREST IS EXCLUDED FROM THE DISCUSSION AND APPROVAL OF SUCH TRANSACTION; (4) IF WARRANTED, ALTERNATIVES TO THE PROPOSED TRANSACTIONS ARE INVESTIGATED, COMPETITIVE BIDS OR COMPARABLE VALUATIONS ARE ATTAINED; (5) ANY CONFLICTING ISSUES DURING THE COURSE OF A BOARD MEETING WHICH CANNOT BE RESOVLED ARE REFERRED TO THE GOVERNANCE COMMITTEE; AND (6) THE TRANSACTION OR ACTION MUST BE APPROVED BY A MAJORITY OF DISINTERESTED PERSONS. ALL CONFLICTS OF INTEREST, WHETHER RESOLVED OR UNRESOLVED, ARE REPORTED IN THE FOUNDATION'S FORM 990. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION DOES NOT EMPLOY PERSONNEL. HOWEVER, THE TOP MANAGEMENT AND FINANCIAL OFFICIALS ARE COMPENSATED BY DIGNITY HEALTH. COMPENSATIONS PLANS ARE REVIEWED CONSISTENT WITH DIGNITY HEALTH'S POLICIES AND PROCEDURES. FOR COMPENSATION, DIGNITY HEALTH'S HUMAN RESOURCES AND COMPENSATION COMMITTEE APPROVES, CONSISTENT WITH THE ORGANIZATION'S PHILOSOPHY AND PRINCIPLES, THE ANNUAL PERFORMANCE GOALS AND CRITERIA TO BE USED IN DETERMINING MERIT INCREASES AND VARIABLE COMPENSATION COMMITTEE ALSO ENGAGES OUTSIDE LEGAL COUNSEL AS NECESSARY AND QUALIFIED INDEPENDENT COMPENSATION AND BENEFITS SPECIALISTS (INDEPENDENT EXPERTS) TO REVIEW, ANALYSE AND PROVIDE BENCHMARKING DATA FOR THE TOTAL COMPENSATION AND BENEFITS PACKAGES OF OFFICERS AND KEY EXECUTIVES. APPROPRIATE COMPARABLE DATA IS OBTAINED FROM THE INDEPENDENT EXPERTS, (E.G., TOTAL ECONOMIC BENEFITS PAID BY SIMILARLY SITUATED ORGANIZATIONS, BOTH TAXABLE AND TAX-EXEMPT, FOR SIMILAR JOB RESPONSIBILITIES). KEY DELIBERATIONS OF THE COMMITTEE ARE DOCUMENTED IN MEETING MINUTES WHICH ARE APPROVED AT THE NEXT COMMITTEE MEETING AND PROVIDED TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 FEDERAL TAX LAWS DO NOT MANDATE THAT THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENT BE MADE AVAILABLE FOR PUBLIC INSPECTION. THE ORGANIZATION MAKES ITS CONSOLIDATED FINANCIAL STATEMENTS AVAILABLE ON ITS WEBSITE AND UPON REQUEST. FORM 990, PART IX, LINE 11G ADMINISTRATIVE SERVICES: PROGRAM SERVICE EXPENSES 4,171,126. MANAGEMENT AND GENERAL EXPENSES 403,893. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 4,575,019. CATERING EXPENSES: PROGRAM SERVICE EXPENSES 22,848. MANAGEMENT AND GENERAL EXPENSES 58,582. FUNDRAISING EXPENSES 5,966. TOTAL EXPENSES 87,396. PHOTOGRAPHY EXPENSE: PROGRAM SERVICE EXPENSES 0. MANAGEMENT AND GENERAL EXPENSES 750. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 750. CONSULTING: PROGRAM SERVICE EXPENSES 376,871. MANAGEMENT AND GENERAL EXPENSES 99,234. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 476,105. CONTRACTORS: PROGRAM SERVICE EXPENSES 6,701,259. MANAGEMENT AND GENERAL EXPENSES 1,308. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 6,702,567. OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 120,756. MANAGEMENT AND GENERAL EXPENSES 6,094. FUNDRAISING EXPENSES 741. TOTAL EXPENSES 127,591. FORM 990, PART XI, LINE 9: DONOR RECISION OF PROMISE TO GIVE. -1,189,733. NEUROTRIALS LLC 2910 N 3RD AVENUE SUITE 450 PHOENIX AZ 85013 831161226 MEDICAL RESEARCH AZ 9545323 50777542 BARROW NEUROLOGICAL FOUNDATION